The U.S. Food and Drug Administration (FDA) recently published testing results for per- and polyfluoroalkyl substances (PFAS) in foods collected as part of its Total Diet Study (TDS), and has provided an update on the agency’s activities to better understand and address PFAS in the U.S. food supply, including an updated analytical method to measure the chemicals. 

The U.S. Food and Drug Administration (FDA) is partnering with the Association of Food and Drug Officials (AFDO) and the National Environmental Health Association (NEHA) to present upcoming Retail Food Regulatory Program Standards Self-Assessment and Verification Audit (SAVA) Workshops at industry events taking place during summer 2024.

On May 3, 2024 the U.S. Food and Drug Administration (FDA) will hold a webinar featuring representatives from the State of Iowa and Richmond County, North Carolina who will discuss how their jurisdictions achieved conformance with all nine of FDA’s Voluntary National Retail Food Regulatory Program Standards.

Allergen-related food recalls have increased since the introduction of FDA's Food Safety Modernization Act in 2011. This article shares the fundamentals of conducting an allergen gap assessment to help companies comply with new FDA guidance on allergen management.

In evaluating the thousands of existing PFAS compounds and at what level they present a risk to the health of humans and animals, FDA, USDA, CPSC, and EPA are focusing on three issues: bioaccumulation, persistence, and toxicity.

This article discusses the recent wave of state bills on food additives that have emerged following the California Food Safety Act, FDA’s activities in an effort to get ahead of an inconsistent patchwork of legislation, and criticisms about these bills voiced by legislators, regulators, and industry stakeholders.

Results of sampling and testing of imported honey for signs of economically motivated adulteration conducted by the U.S. Food and Drug Administration (FDA) in 2022–2023 has revealed only 3 percent of samples to be violative.

In this episode of Food Safety Matters, we are joined by James (Jim) Jones, FDA's first Deputy Commissioner for Human Foods, about his charge of implementing and leading a unified and effective Human Foods Program, the importance of stakeholder engagement in decision-making, and the agency’s current work in food safety.

The U.S. House of Representatives’ Committee on Oversight and Accountability will hold a hearing on April 11, 2024 to question FDA Commissioner Robert M. Califf, M.D. about the agency’s failure to prevent recent food safety crises.

In light of recently confirmed cases of highly pathogenic avian influenza (HPAI) in U.S. dairy cows and now in one person, James (Jim) Jones, FDA Deputy Commissioner for Human Foods revealed that HPAI has become the “highest priority” within the agency’s Human Foods Program, and that the agency has set up a set up a dedicated Incident Management Team (IMT) to respond to the developing threat.